Nup107 is a crucial regulator of torso-mediated metamorphic transition in Drosophila melanogaster
Figures
Nup107 depletion impairs metamorphosis.
Analysis of Nup107 depletion and its impact on growth and development of organism. (A) Growth profile of third instar larvae from Actin5C-Gal4-driven control and Nup107 knockdowns (Nup107GD and Nup107KK RNA interference [RNAi] lines) at 96 hr AEL (after egg laying) and 120 hr AEL. (B) Quantitation of Nup107 knockdown efficiency. Data are represented from at least three independent experiments. Statistical significance was derived from the Student’s t-test. Error bars represent SEM. **p=<0.001 and ****p=<0.0001. (C) Immunodetection of Nup107 protein levels in third instar larval brain-complex lysates from control and Nup107 knockdown. (D) Quantification of Nup107 protein levels seen in (C). Data are represented from at least three independent experiments. Statistical significance was derived from the Student’s t-test. Error bars represent SEM. ***p=<0.0002 and ****p=<0.0001. (E) Comparison of pupariation profiles of control and Nup107 knockdown organisms.
-
Figure 1—source data 1
Western blot analysis of Nup107 knockdown.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig1-data1-v1.zip
-
Figure 1—source data 2
Original files for larval images and western blot analysis displayed in Figure 1.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig1-data2-v1.zip
-
Figure 1—source data 3
Numerical values of graphs are shown in Figure 1.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig1-data3-v1.xlsx
Nup107 staining in salivary glands.
(A-B) Custom-generated polyclonal anti-Nup107 antibody colocalizes with pan-FG-Nup antibody, mAb414 (A), and mRFP-tagged Nup107 (B) at the nuclear rim of the third instar salivary gland. DNA stained with DAPI. Scale bars, 20 µm.
-
Figure 1—figure supplement 1—source data 1
Original confocal images are presented for Figure 1—figure supplement 1.
The cells highlighted in the yellow box were included in the supplementary figure. The upper panel corresponds to Figure 1—figure supplement 1A, while the lower panel corresponds to Figure 1—figure supplement 1B.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig1-figsupp1-data1-v1.zip
-
Figure 1—figure supplement 1—source data 2
Original files for confocal images are displayed in Figure 1—figure supplement 1.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig1-figsupp1-data2-v1.zip
Nup107 CRISPR mutant generation.
(A) Schematic representation of Nup107KO generation. (Ai) The genomic locus of nup107 on chromosome-II (2L). The filled black box corresponds to the nup107 ORF (2779 bp) with gRNA(s) positions indicated by red arrows. The first and second gRNAs were designed near start and stop codons, respectively, of the nup107 locus. (Aii) Blue and green arrows indicate two sets of primers located in the 5’-UTR and 3’-UTR regions used for screening of Nup107 mutant. (Aiii) The black discontinuous line represents the nup107 (2752 bp) deletion allele. (B) Confirmation of Nup107 deletion mutant (heterozygous) line assessed by the presence of an ~630 bp band amplified from isolated genomic DNA.
-
Figure 1—figure supplement 2—source data 1
The original DNA gel image corresponds to Figure 1—figure supplement 2B.
The first lane displays wild-type samples (+/+), while the second lane shows a heterozygous sample (+/-), which has one copy of Nup107 deleted. The third lane contains the DNA ladder.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig1-figsupp2-data1-v1.zip
-
Figure 1—figure supplement 2—source data 2
The raw original DNA gel image corresponds to Figure 1—figure supplement 2B.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig1-figsupp2-data2-v1.zip
Ubiquitous knockdown of Nup107 disrupts ecdysone signaling.
Assessment of ecdysone receptor-dependent signaling in salivary glands of third instar larvae. (A–B) Staining of third instar larval salivary glands from control (A) and ubiquitous Nup107 knockdown (B) with ecdysone receptor (EcR) (anti-EcR antibody, red) and Nup107 (anti-Nup107 antibody, green). DNA is stained with DAPI. Scale bars, 20 μm. Charts represent the line scan intensity profile of EcR (red) and DAPI (cyan) in the salivary gland nucleus region. (C) Quantification of the nucleocytoplasmic ratio of EcR under control and Nup107 knockdown conditions. At least 45 nuclei were analyzed from seven to eight pairs of salivary glands. Statistical significance was derived from the Student’s t-test. Error bars represent SEM. ****p=<0.0001. (D–F) Analysis of ecdysone-inducible genes, EcR (D), Eip75A (E), and Eip74EF (F) expression, respectively, at the onset of metamorphosis (late third instar larvae stage). Data are represented from at least three independent experiments. Statistical significance was derived from the Student’s t-test. The error bars represent the SEM. ***p=<0.0004 and ****p=<0.0001.
-
Figure 2—source data 1
Original confocal images for Figure 2, showing the EcR localization in Nup107-depleted tissues.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig2-data1-v1.zip
-
Figure 2—source data 2
Original files for the confocal images presented in Figure 2.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig2-data2-v1.zip
-
Figure 2—source data 3
Numerical values of graphs are shown in Figure 2.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig2-data3-v1.xlsx
Compromised organ size due to ubiquitous depletion of Nup107: Actin5C-Gal4 was used as a ubiquitous driver.
(A-B) Third instar larval salivary gland (A), and brain complex (B) images of Control, Nup107KK RNAi and Nup107GD RNAi. DNA stained with DAPI. Scale bars are 200 µm and 100 µm in (A) and (B), respectively.
-
Figure 2—figure supplement 1—source data 1
Original confocal images are presented for Figure 1—figure supplement 1.
The upper panel corresponds to salivary gland images, while the lower panel corresponds to brain complex images.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig2-figsupp1-data1-v1.zip
Ubiquitous knockdown of Nup107 using Nup107GD RNA interference (RNAi) disrupts ecdysone signaling.
(A–B) Staining of third instar larval salivary glands from control (A) and ubiquitous Nup107GD knockdown (B) with ecdysone receptor (EcR) (anti-EcR antibody, red) and Nup107 (anti-Nup107 antibody, green). DNA is stained with DAPI, and scale bars, 20 μm. Charts represent the line scan intensity profile of EcR (red) and DAPI (cyan) in the salivary gland nucleus region. (C) Quantification of nucleocytoplasmic ratio of EcR under control and Nup107 knockdown conditions. At least 45 nuclei were analyzed from seven to eight pairs of salivary glands. Statistical significance was derived from the Student’s t-test. Error bars represent SEM. ****p=<0.0001. (D–F) Analysis of ecdysone-inducible genes, EcR (D), Eip75A (E), and Eip74EF (F) expression. Data are represented from at least three independent experiments. Statistical significance was derived from the Student’s t-test. The error bars represent the SEM. ***p=<0.0007 and ****p=<0.0001.
-
Figure 2—figure supplement 2—source data 1
Original images for Figure 2—figure supplement 2 are shown.
The cells highlighted in the yellow box were included in the supplementary figure.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig2-figsupp2-data1-v1.zip
-
Figure 2—figure supplement 2—source data 2
Original files for the confocal images presented in Figure 2—figure supplement 2.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig2-figsupp2-data2-v1.zip
-
Figure 2—figure supplement 2—source data 3
Numerical values of graphs are shown in Figure 2—figure supplement 2.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig2-figsupp2-data3-v1.xlsx
Targeted knockdown of Nup107 in the prothoracic gland (PG) perturbs ecdysone signaling pathway.
Analyzing the impact of tissue-specific Nup107 depletion on ecdysone receptor (EcR) signaling in third instar larval salivary glands. (A–C) Detection and quantitation of nucleocytoplasmic distribution of EcR (anti-EcR antibody, red) and Nup107 (anti-Nup107 antibody, green) in control (A), salivary gland-specific Nup107 depletion (B), and prothoracic gland-specific Nup107 depletion (C) from third instar larval salivary gland nuclei. DNA is stained with DAPI. Scale bars, 20 μm. Charts represent the line scan intensity profile of EcR (red) and DAPI (cyan) in the salivary gland nucleus region. (D) EcR nucleocytoplasmic quantification ratio from the salivary gland and prothoracic gland-specific Nup107 knockdown, respectively. At least 45 nuclei were analyzed from seven to eight pairs of salivary glands. Statistical significance was derived from the Student’s t-test. Error bars represent SEM. ****p=<0.0001, and ns is nonsignificant. (E–F) Quantitation of expression of Eip75A (E) and Eip74EF (F) ecdysone-inducible genes at the onset of metamorphosis (RNA isolated from late third instar larvae of control and prothoracic gland-specific Nup107 depletion). Data are represented from at least three independent experiments. Statistical significance was derived from the Student’s t-test. Error bars represent SEM. **p=<0.008 and ****p=<0.0001.
-
Figure 3—source data 1
Original confocal images for Figure 3, showing the EcR localization in Nup107-depleted tissues.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig3-data1-v1.zip
-
Figure 3—source data 2
Original files for the confocal images presented in Figure 3.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig3-data2-v1.zip
-
Figure 3—source data 3
Numerical values of graphs are shown in Figure 3.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig3-data3-v1.xlsx
Nup107GD RNA interference (RNAi)-mediated Nup107 depletion regulates ecdysone receptor (EcR)-dependent signaling.
(A–C) Detection and quantitation of nucleocytoplasmic distribution of EcR (anti-EcR antibody, red) and Nup107 (anti-Nup107 antibody, green) in control (A), salivary gland-specific Nup107GD depletion (B), and prothoracic gland-specific Nup107GD depletion (C) from third instar larval salivary gland nuclei. DNA is stained with DAPI. Scale bars, 20 μm. Charts represent the line scan intensity profile of EcR (red) and DAPI (cyan) in the salivary gland nucleus region. (D) EcR nucleocytoplasmic quantification ratio from salivary gland and prothoracic gland-specific Nup107 knockdown. At least 45 nuclei were analyzed from seven to eight pairs of salivary glands. Statistical significance was derived from the Student’s t-test. Error bars represent SEM. ****p=<0.0001, and ns is nonsignificant. (E–F) Quantitation of expression of Eip75A (E) and Eip74EF (F) ecdysone-inducible genes at the onset of metamorphosis (RNA isolated from late third instar larval stage). Data are represented from at least three independent experiments. Statistical significance was derived from the Student’s t-test. Error bars represent SEM. ****p=<0.0001.
-
Figure 3—figure supplement 1—source data 1
Original images for Figure 3—figure supplement 1 are shown.
The cells highlighted in the yellow box were included in the supplementary figure.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig3-figsupp1-data1-v1.zip
-
Figure 3—figure supplement 1—source data 2
Original files for the confocal images presented in Figure 3—figure supplement 1.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig3-figsupp1-data2-v1.zip
-
Figure 3—figure supplement 1—source data 3
Numerical values of graphs are shown in Figure 3—figure supplement 1.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig3-figsupp1-data3-v1.xlsx
Nup107 regulates metamorphosis via ecdysone synthesis.
(A) Growth profile of third instar larvae from AB1-Gal4-driven control and Nup107 knockdowns (Nup107KK and Nup107GD RNA interference [RNAi] lines) at 96 hr AEL (hours after egg laying) and 120 hr AEL. (B) Growth profile of third instar larvae from Phm-Gal4-driven control and Nup107 knockdowns (Nup107KK and Nup107GD RNAi lines) at 96 hr AEL and 120 hr AEL. (C) Comparison of pupariation profiles of control and Nup107 knockdown organisms.
-
Figure 3—figure supplement 2—source data 1
Original images corresponding to Figure 3—figure supplement 2.
The upper panel corresponds to Figure 3—figure supplement 2A, and the lower panel corresponds to Figure 3—figure supplement 2B.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig3-figsupp2-data1-v1.zip
-
Figure 3—figure supplement 2—source data 2
Original files for Figure 3—figure supplement 2.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig3-figsupp2-data2-v1.zip
-
Figure 3—figure supplement 2—source data 3
Numerical values of graphs are shown in Figure 3—figure supplement 2.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig3-figsupp2-data3-v1.xlsx
Nup107 depletion compromises the prothoracic gland (PG) size.
(A–C) PG-specific driver Phm-Gal4-driven expression of GFP in the PGs of the third instar larva image of control (A), Nup107KK RNA interference (RNAi) (B), and Nup107GD RNAi (C). DNA stained with DAPI. Scale bars, 20 µm.
-
Figure 3—figure supplement 3—source data 1
The original confocal images of the prothoracic glands correspond to Figure 3—figure supplement 3.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig3-figsupp3-data1-v1.zip
-
Figure 3—figure supplement 3—source data 2
Original files for Figure 3—figure supplement 3.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig3-figsupp3-data2-v1.zip
Nup107 critically regulates the expression of ecdysone-biosynthetic genes.
(A) Enzyme-linked immunosorbent assay (ELISA) measurements of whole-body 20-hydroxyecdysone (20E) levels in control, ubiquitous (Actin5C-Gal4), and prothoracic gland-specific (Phm-Gal4) Nup107 depletion at 96 and 120 hr after egg laying (AEL). Data are represented from at least three independent experiments. Statistical significance was derived from the Student’s t-test. Error bars represent SEM. *p=<0.032, **p=<0.0078, and ns is nonsignificant. (B) Schematic representation of a prothoracic gland cell showing genes involved in ecdysone biosynthesis from cholesterol. (C–G) Quantification of ecdysone-biosynthetic gene expression levels of spookier (C), phantom (D), disembodied (E), shadow (F), and shade (G) in cDNA isolated from control and Nup107 knockdown late third instar larvae. Data are represented from at least three independent experiments. Statistical significance was derived from the Student’s t-test. Error bars represent SEM. **p=<0.001, ***p=<0.0005, and ****p=<0.0001. Created with BioRender.com.
-
Figure 4—source data 1
Numerical values of graphs are shown in Figure 4.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig4-data1-v1.xlsx
Nup107GD RNA interference (RNAi)-mediated depletion of Nup107 critically regulates the expression of ecdysone-biosynthetic genes.
(A) Enzyme-linked immunosorbent assay (ELISA) measurements of whole-body 20-hydroxyecdysone (20E) levels in control and prothoracic gland-specific (Phm-Gal4) Nup107GD depletion at 96 and 120 hr after egg laying (AEL). Data are represented from at least three independent experiments. Statistical significance was derived from the Student’s t-test. Error bars represent SEM. **p=<0.0025, and ‘ns’ is nonsignificant. (B–F) Quantification of ecdysone-biosynthetic gene expression levels of spookier (B), phantom (C), disembodied (D), shadow (E), and shade (F) in cDNA isolated from control and Nup107 knockdown late third instar larvae. Data are represented from at least three independent experiments. Statistical significance was derived from the Student’s t-test. Error bars represent SEM. ****p=<0.0001, ***p=<0.0005, **p=<0.001, and *p=<0.03.
-
Figure 4—figure supplement 1—source data 1
Numerical values of graphs are shown in Figure 4—figure supplement 1.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig4-figsupp1-data1-v1.xlsx
20-Hydroxyecdysone (20E) supplementation rescues Nup107 depletion-specific ecdysone receptor (EcR) signaling defects.
Immunofluorescence analysis of EcR localization in 20E supplemented and non-supplemented third instar larval salivary glands. (A–F) Visualization of the nucleocytoplasmic distribution of EcR (anti-EcR antibody, red) without 20E (A–C) and with 20E (D–F) treatment in larval salivary glands of control, ubiquitous (Actin5C-Gal4) Nup107 knockdown, and prothoracic gland-specific (Phm-Gal4) Nup107 knockdown. DNA is stained with DAPI. Scale bars, 20 μm. Charts represent the line scan intensity profile of EcR (red) and DAPI (cyan) in the salivary gland nucleus region. (G–H) Comparative quantification of expression ecdysone-inducible genes Eip75A (G) and Eip74EF (H) from 20E-treated salivary glands. Data are represented from at least three independent experiments. Statistical significance was derived from the Student’s t-test. Error bars represent SEM. *p=<0.02, **p=<0.002, ***p=<0.0008, and ns is nonsignificant.
-
Figure 5—source data 1
Original confocal images for Figure 5, showing the EcR localization with and without 20E.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig5-data1-v1.zip
-
Figure 5—source data 2
Original files for Figure 5.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig5-data2-v1.zip
-
Figure 5—source data 3
Numerical values of graphs are shown in Figure 5.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig5-data3-v1.xlsx
Ecdysone (20-hydroxyecdysone [20E]) supplementation rescues Nup107GD-dependent Nup107 depletion-specific ecdysone receptor (EcR) signaling defects.
(A–B) Visualization of the nucleocytoplasmic distribution of EcR (anti-EcR antibody, red) without 20E (A) and with 20E (B) treatment in larval salivary glands of control, ubiquitous (Actin5C-Gal4) Nup107GD knockdown, and prothoracic gland-specific (Phm-Gal4) Nup107GD knockdown. DNA is stained with DAPI. Scale bar, 20 μm. Charts represent the line scan intensity profile of EcR (red) and DAPI (cyan) in the salivary gland nucleus region.
-
Figure 5—figure supplement 1—source data 1
Original images for without 20-hydroxyecdysone (20E) (Figure 5—figure supplement 1A) and with 20E (Figure 5—figure supplement 1B) are shown.
The cells highlighted in the yellow box were included in the supplementary figure.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig5-figsupp1-data1-v1.zip
-
Figure 5—figure supplement 1—source data 2
Original files for Figure 5—figure supplement 1.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig5-figsupp1-data2-v1.zip
-
Figure 5—figure supplement 1—source data 3
Numerical values of graphs are shown in Figure 5—figure supplement 1.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig5-figsupp1-data3-v1.xlsx
Torso and Nup107 act synergistically to activate the ecdysone signaling.
(A) A model of the Torso pathway and its components. (B) Quantitation of torso transcript levels from control and Nup107-depleted larvae (ubiquitous depletion using Actin5C-Gal4). Data are represented from at least three independent experiments. Statistical significance was derived from the Student’s t-test. Error bars represent SEM. ****p=<0.0001. (C–D) Comparison of pupariation profiles of control, Nup107 knockdown, and torso and rasV12 overexpressing rescue organisms. (E–G) Detection and quantitation of nucleocytoplasmic distribution of EcR (anti-EcR antibody, red) and Nup107 (anti-Nup107 antibody, green) in control, torso overexpressing ubiquitous Nup107 knockdown (Actin5C-Gal4>Nup107KK; UAS-torso) and torso overexpressing PG-specific Nup107 knockdown (Phm-Gal4>Nup107KK; UAS-torso) third instar larval salivary gland nuclei. DNA is stained with DAPI. Scale bars, 20 μm. Charts show the line scan intensity profiles of EcR (red) and DAPI (cyan) in the salivary gland nucleus region. (H–I) Quantification of expression of Eip75A (H) and Eip74EF (I) ecdysone-inducible genes, respectively. Data are represented from at least three independent experiments. Statistical significance was derived from the Student’s t-test. Error bars represent SEM. *p=<0.03, **p=<0.008, ****p=<0.0001, and ns is nonsignificant. Created with BioRender.com.
-
Figure 6—source data 1
Original confocal images for the confocal images presented in Figure 6.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig6-data1-v1.zip
-
Figure 6—source data 2
Original files for the confocal images presented in Figure 6.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig6-data2-v1.zip
-
Figure 6—source data 3
Numerical values of graphs are shown in Figure 6.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig6-data3-v1.xlsx
Torso rescues metamorphic defects of Nup107 knockdown.
(A) Growth profile of third instar larvae from different genotypes (control, Nup107KK, Nup107KK;UAS-torso, and Nup107KK;UAS-rasV12) at 96 hr AEL (after egg laying). (B–E) Quantification of ecdysone-biosynthetic gene expression levels of spookier (B), phantom (C), disembodied (D), and shadow (E) in cDNA isolated from control and Nup107-depleted torso overexpressing larvae (by using Actin5C-Gal4 and Phm-Gal4). Data are represented from at least three independent experiments. Statistical significance was derived from the Student’s t-test. Error bars represent SEM. (*) represents p<0.03, and ‘ns’ is nonsignificant.
-
Figure 6—figure supplement 1—source data 1
Uncropped image of larvae corresponding to Figure 6—figure supplement 1.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig6-figsupp1-data1-v1.zip
-
Figure 6—figure supplement 1—source data 2
Original files of larval images of Figure 6—figure supplement 1.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig6-figsupp1-data2-v1.zip
-
Figure 6—figure supplement 1—source data 3
Numerical values of graphs are shown in Figure 6—figure supplement 1.
- https://cdn.elifesciences.org/articles/105165/elife-105165-fig6-figsupp1-data3-v1.xlsx
Theoretical model of Nup107 functions in metamorphosis.
During metamorphosis, the prothoracic gland (PG) responds to prothoracicotropic hormone (PTTH) via Torso receptors. The MAP kinase pathway involving Raf, MEK, and ERK, initiated by Ras, leads to Halloween gene expression responsible for ecdysone synthesis and release. Ecdysone is converted to active 20-hydroxyecdysone (20E) in peripheral tissues. The binding of 20E to the ecdysone receptor (EcR) allows EcR nuclear translocation and EcR pathway activation, culminating in target gene expression facilitating the metamorphic transition. Nup107 depletion negatively impacts Torso levels and Torso pathway activation, inducing pupariation arrest, which can be rescued by autonomous activation of the Torso pathway. Created with BioRender.com.
Nup107 depletion does not perturb overall NPC composition.
Comparison of salivary gland nucleus upon control and Nup107 knockdown. The Nup107 is shown in green and mAb414, staining for other FG-repeat containing nucleoporins is shown in red. Scale bars, 5µm.
Nup107 levels are significantly reduced upon Nup107KK RNAi.
Quantification of Nup107 transcript levels from control and Nup107 depleted larvae [tissue specific depletion using AB1-Gal4 (A) and Phm-Gal4 (B)]. Data are represented from at least three independent experiments. Statistical significance was derived from the Student’s t-test. Error bars represent SEM. **p = <0.004
Nup107 knockdown does not affect the PTTH level.
Quantitation of PTTH transcript levels from control and Nup107 depleted larvae (Prothoracic specific depletion Phm-Gal4). Data are represented from at least three independent experiments. Statistical significance was derived from the Student's t-test. ns is non-significant.
Prothoracic gland’s specific torso expression rescues EcR nuclear translocation defects.
Immunofluorescence-based detection of nucleocytoplasmic distribution of EcR (EcR antibody, red) in control, prothoracic gland specific Nup107 knockdown (Phm-Gal4>Nup107KK) and torso overexpressing PG-specific Nup107 knockdown (Phm-Gal4>Nup107KK; UAS-torso) third instar larval Prothoracic gland nuclei. DNA is stained with DAPI. Scale bars, 20 μm.
Nup107 regulates torso activation dependent p-ERK localization.
Detection of nucleocytoplasmic distribution of p-ERK (anti- p-ERK antibody, green) in the third instar larval prothoracic glands of control, PG-specific Nup107 knockdown (Phm-Gal4>Nup107KK) and PG-specific torso overexpression in Nup107 knockdown background (Phm-Gal4>Nup107KK; UAS-torso). DNA is stained with DAPI. Scale bars, 20 µm.
Tables
| Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
|---|---|---|---|---|
| Genetic reagent (D. melanogaster) | w1118 | Bloomington Drosophila Stock Center | BDSC:3605; FLYB: FBst000360; RRID:BDSC_3605 | w[1,118] |
| Genetic reagent (D. melanogaster) | w1118; P{GD12024}v22407 | Vienna Drosophila Resource Center | VDRC: v22407; FLYB: FBst0454535; RRID:FlyBase_ FBst0454535 | P{GD12024}v22407 (Nup107GD RNAi) |
| Genetic reagent (D. melanogaster) | P{KK108047}VIE-260B | VDRC: v110759; FLYB: FBst0482324; RRID:FlyBase_FBst0482324 | P{KK108047}VIE-260B (Nup107KK RNAi) | |
| Genetic reagent (D. melanogaster) | y[1] w[*]; P{w[+mW.hs]=GawB}AB1 | Bloomington Drosophila Stock Center | BDSC:1824; FLYB: FBti0001249; RRID:BDSC_1824 | AB1-Gal4 |
| Genetic reagent (D. melanogaster) | y[1] w[*]; P{w[+mC]=phtm-GAL4.O}22 | BDSC:80577; FLYB: FBti0201787; RRID:BDSC_80577 | Phm-Gal4 | |
| Genetic reagent (D. melanogaster) | y[1] w[*]; P{Act5C-GAL4-w}E1/CyO | BDSC:25374; FLYB: FBti0127834; RRID:BDSC_25374 | Actin5C-Gal4 | |
| Genetic reagent (D. melanogaster) | w[*]; wg[Sp-1]/CyO; P{w[+mC]=mRFP-Nup107.K}7.1 | BDSC:35517; FLYB: FBti0130064; RRID:BDSC_35517 | mRFP-Nup107 | |
| Genetic reagent (D. melanogaster) | y[1] M{w[+mC]=nanos-Cas9.P}ZH-2A w[*] | Bloomington Drosophila Stock Center | BDSC:54591; FLYB: FBti0159183; RRID:BDSC_54591 | Nanos.Cas9 |
| Genetic reagent (D. melanogaster) | w[*]; TI{w[+mW.hs]=TI}trk[Delta]/CyO; P{w[+mC]=UASp-tor.G}5.7 | BDSC:92604; FLYB: FBti0216047; RRID:BDSC_92604 | UAS-torso | |
| Genetic reagent (D. melanogaster) | w[1118]; P{w[+mC]=UAS-Ras85D.V12}TL1 | BDSC:4847; FLYB: FBti0012505; RRID:BDSC_4847 | UAS-rasV12 | |
| Genetic reagent (D. melanogaster) | Nup107KK;UAS-GFP | Generated in the RKM (corresponding authors) laboratory and details are reported in the Materials and methods under Fly stocks and genetics section. | ||
| Genetic reagent (D. melanogaster) | UAS-GFP;Nup107GD | |||
| Genetic reagent (D. melanogaster) | UAS-GFP;Phm-Gal4/TM6.Tb | |||
| Genetic reagent (D. melanogaster) | Nup107 gRNA line | |||
| Genetic reagent (D. melanogaster) | Nup107KK;UAS-torso | |||
| Genetic reagent (D. melanogaster) | Nup107KK;UAS-rasV12 | |||
| Antibody | Anti-Nup107 (Rabbit polyclonal) | This study | WB (1:500), IF (1:100) Generated in the RKM (corresponding authors) laboratory and details are reported in the Materials and methods under antibody generation and western blotting section. | |
| Antibody | Anti-Nuclear Pore Complex Proteins (Mouse monoclonal) | BioLegend | Cat#902902 (MAb414) | IF (1:500) |
| Antibody | Anti-EcR (Mouse monoclonal) | DSHB | Cat#DDA2.7 | IF (1:20) |
| Antibody | Anti-α tubulin (Mouse monoclonal) | DSHB | Cat#12G10 | IB (1:5000) |
| Antibody | Goat anti-rabbit Alexa Fluor Plus 680 | Thermo Fisher Scientific | Cat#A32734 | IB (1:40,000) |
| Antibody | Goat anti-mouse Alexa Fluor Plus 800 | Cat#A32730 | IB (1:40,000) | |
| Antibody | Goat anti-rabbit Alexa Fluor 488 | Cat#A11034 | IF (1:800) | |
| Antibody | Goat anti-rabbit Alexa Fluor 568 | Cat#A11036 | IF (1:800) | |
| Antibody | Goat anti-mouse Alexa Fluor 488 | Cat#A11029 | IF (1:800) | |
| Antibody | Goat anti-mouse Alexa Fluor 568 | Cat#A11004 | IF (1:800) | |
| Antibody | Goat anti-rabbit Alexa Fluor 647 | Jackson ImmunoResearch | Cat#111-605-045 | IF (1:800) |
| Sequence-based reagent | Nup107_gRNA1 | Generated in the RKM (corresponding authors) laboratory and details are reported in the material and methods under antibody generation and western blotting, Nested PCR, Quantitative RT-PCR, Transgenic fly generation sections | PCR primers (5'–3'): | TGGCCGACAGCCCGTTCCCG |
| Sequence-based reagent | Nup107_ gRNA2 | PCR primers (5'–3'): | GGAGCTGCTCAACTCGAAACTGG | |
| Sequence-based reagent | 5’UTR Primer1_F | PCR primers (5'–3'): | GCTCCCAAATACTCGCTGCC | |
| Sequence-based reagent | 3’UTR Primer1_R | PCR primers (5'–3'): | CTTCTGCCGGCGGATTTGTT | |
| Sequence-based reagent | 5’UTR Primer2_F | PCR primers (5'–3'): | GGTACCCCATACTAATGATTC | |
| Sequence-based reagent | 3’UTR Primer2_R | PCR primers (5'–3'): | CATGTTGTTTGTCTCGCTACT | |
| Sequence-based reagent | Nup107 (for antibody generation) | PCR primers (5'–3'): | Forward: ATCGGATCCATGGCCGACAGCCCGTTC Reverse: ATCGAATTCCTACCACGCCATCATACGATC | |
| Sequence-based reagent | Nup107_RT | PCR primers (5'–3'): | Forward: GCAGGCTCACCGATCGGAAG Reverse: TCCATCTGCAGTAGGCGATG | |
| Sequence-based reagent | EcR_RT | PCR primers (5'–3'): | Forward: AAGAGGATCTCAGGCGTATAA Reverse: GGCCTTTAGTAACGTGATCTG | |
| Sequence-based reagent | Eip75A_RT | PCR primers (5'–3'): | Forward: ACCACAGCACCACCCATTT Reverse: TGTTTGGCGGTAGTTTCAGG | |
| Sequence-based reagent | Eip74EF_RT | PCR primers (5'–3'): | Forward: CTCTGCTCCACATAAAGACG Reverse: CCGCTAAGCAGATTGTGG | |
| Sequence-based reagent | Phm_RT | PCR primers (5'–3'): | Forward: GGATTTCTTTCGGCGCGATGTG Reverse: TGCCTCAGTATCGAAAAGCCGT | |
| Sequence-based reagent | Spok_RT | PCR primers (5'–3'): | Forward: TATCTCTTGGGCACACTCGCTG Reverse: GCCGAGCTAAATTTCTCCGCTT | |
| Sequence-based reagent | Dib_RT | PCR primers (5'–3'): | Forward: TGCCCTCAATCCCTATCTGGTC Reverse: ACAGGGTCTTCACACCCATCTC | |
| Sequence-based reagent | Sad_RT | PCR primers (5'–3'): | Forward: CCGCATTCAGCAGTCAGTGG Reverse: ACCTGCCGTGTACAAGGAGAG | |
| Sequence-based reagent | Shd_RT | PCR primers (5'–3'): | Forward: CGGGCTACTCGCTTAATGCAG Reverse: AGCAGCACCACCTCCATTTC | |
| Sequence-based reagent | Torso_RT | PCR primers (5'–3'): | Forward: CAGCTACTGCGACAAGGTCATCG Reverse: CTCGGTTGCAGCTTGCAGTTG | |
| Sequence-based reagent | Rpl49_RT | PCR primers (5'–3'): | Forward: CGTTTACTGCGGCGAGAT Reverse: GTGTATTCCGACCACGTTACA | |
| Commercial assay or kit | RNA isolation kit | Favorgen Biotech | Cat#FATRK-001–2 | |
| Commercial assay or kit | iScriptTM cDNA synthesis kit | Bio-Rad | Cat#170–8891 | |
| Commercial assay or kit | 20-Hydroxyecdysone ELISA kit | Thermo Fisher Scientific | Cat#EIAHYD | |
| Chemical compound, drug | Fluoroshield | Sigma-Aldrich | Cat#F6057 | |
| Chemical compound, drug | Triton X-100 | Cat#X100-1L | ||
| Chemical compound, drug | Tween-20 | Cat#274348 | ||
| Chemical compound, drug | Paraformaldehyde | Cat#158127 | ||
| Chemical compound, drug | iTaq Universal SYBR Green Supermix | Bio-Rad | Cat#1725122 | |
| Chemical compound, drug | G9 Taq Polymerase 10× buffer with MgCl2 | GCC Biotech | Cat#G7115 | |
| Chemical compound, drug | dNTPs | SBS GENETECH | Cat#EN-2 | |
| Chemical compound, drug | 20-Hydroxyecdysone | Sigma-Aldrich | Cat# H5142 | |
| Chemical compound, drug | EDTA | Sigma-Aldrich | Cat#03690 | |
| Chemical compound, drug | SDS | HIMEDIA | Cat#GRM886 | |
| Chemical compound, drug | Proteinase K | MP Biomedicals | Cat#193981 | |
| Chemical compound, drug | Tris | HIMEDIA | Cat#MB029 | |
| Chemical compound, drug | Potassium acetate | HIMEDIA | Cat#MB042 | |
| Chemical compound, drug | Isopropanol | MP Biomedicals | Cat#194006 | |
| Chemical compound, drug | Ethanol | Merck | Cat#100983 | |
| Chemical compound, drug | Sucrose | ANJ Biomedicals | Cat#100314 | |
| Chemical compound, drug | IPTG | Sigma-Aldrich | Cat#I6758 | |
| Chemical compound, drug | Protease inhibitor cocktail (PIC) | Roche | Cat#04693132001 | |
| Chemical compound, drug | NaCl | Emparta ACS | Cat#1.93206.0521 | |
| Chemical compound, drug | EGTA | Sigma-Aldrich | Cat#E4378 | |
| Chemical compound, drug | Sodium deoxycholate | Cat# 30970 | ||
| Chemical compound, drug | Sodium azide | Cat#438456 | ||
| Chemical compound, drug | N-Hydroxy-succinimidyl (NHS) Sepharose | Sigma-Aldrich | Cat#H8280 | |
| Chemical compound, drug | Urea | MP Biomedicals | Cat#194857 | |
| Software, algorithm | ImageJ/Fiji | National Institutes of Health, USA | http://imagej.nih.gov/ij/ | |
| Software, algorithm | GraphPad Prism software | GraphPad | https://www.graphpad.com/ | |
| Software, algorithm | Adobe Photoshop 2023 | Adobe | https://www.adobe.com/in/products/photoshop.html | |
| Software, algorithm | QuantStudio Design & Analysis Software | Applied Biosystems | https://www.thermofisher.com/in/en/home/products-and-services/promotions.html |
Additional files
-
Supplementary file 1
Exogenous 20-hydroxyecdysone (20E) supplementation analysis.
- https://cdn.elifesciences.org/articles/105165/elife-105165-supp1-v1.xlsx
-
MDAR checklist
- https://cdn.elifesciences.org/articles/105165/elife-105165-mdarchecklist1-v1.docx